1. Khassafi N, Tameh AA, Mirzaei H, Rafat A, Barati S, Khassafi N, et al. Crosstalk between Nrf2 signaling pathway and inflammation in ischemic stroke: Mechanisms of action and therapeutic implications. Exp Neurol. 2023; 369:114655. doi:10.1016/j.expneurol.2023.114655 PMid:38110142

2. Nejati M, Tameh AA, Vahidinia Z, Atlasi MA. Mesenchymal stem cells improve ischemic stroke injury by anti-inflammatory properties in rat model of middle cerebral artery occlusion. Iran Red Crescent Med J. 2018;20(1). doi:10.5812/ircmj.55085

3. Strain WD, Elyas S, Wedge N, Mounce L, Henley W, James M, et al. Evaluation of microalbuminuria as a prognostic indicator after a TIA or minor stroke in an outpatient setting: the prognostic role of microalbuminuria in TIA evolution (ProMOTE) study. BMJ Open. 2021;11(9):e043253. doi:10.1136/bmjopen-2020-043253 PMid:34489262 PMCid:PMC8422314

4. Hankey GJ. Stroke. Lancet. 2017; 389(10069):641-654. doi:10.1016/S0140-6736(16)30962-X PMid:27637676 PMCid:PMC12123089

5. Samaniego EA, Roa JA, Limaye K, Adams HP Jr. Mechanical thrombectomy: emerging technologies and techniques. J Stroke Cerebrovasc Dis. 2018; 27(10):2555-2571. doi:10.1016/j.jstrokecerebrovasdis.2018.05.025 PMid:29960666

6. Svendsen SP, Svendsen CN. Cell therapy for neurological disorders. Nat Med. 2024;30(10):2756-2770. doi:10.1038/s41591-024-03281-3 PMid:39407034

7. Detante O, Legris L, Moisan A, Rome C. Cell Therapy and Functional Recovery of Stroke. Neuroscience. 2024;550:79-88. doi:10.1016/j.neuroscience.2023.11.027 PMid:38013148

8. Unsworth D, Mathias J, Dorstyn D, Koblar S. Are patient educational resources effective at deterring stroke survivors from considering experimental stem cell treatments? A randomized controlled trial. Patient Educ Couns. 2020;103(7):1373-1381. doi:10.1016/j.pec.2020.02.012 PMid:32081514

9. Cunningham NA, Abhyankar P, Cowie J, Galinsky J, Methven K. Regenerative medicine: stroke survivor and carer views and motivations towards a proposed stem cell clinical trial using placebo neurosurgery. Health Expect. 2018; 21(1): 367-378. doi:10.1111/hex.12632 PMid:29024214 PMCid:PMC5750757

10. George MJ, Prabhakara K, Toledano-Furman NE, Wang YW, Gill BS, Wade CE, et al. Clinical cellular therapeutics accelerate clot formation. Stem Cells Transl Med. 2018;7(10):731-739. doi:10.1002/sctm.18-0015 PMid:30070065 PMCid:PMC6186273

11. Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K. Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells Int. 2019;2019:9628536. doi:10.1155/2019/9628536 PMid:31093291 PMCid:PMC6481040

12. Cai Y, Liu W, Lian L, Xu Y, Bai X, Xu S, et al. Stroke treatment: Is exosome therapy superior to stem cell therapy? Biochimie. 2020;179:190-204. doi:10.1016/j.biochi.2020.09.025 PMid:33010339

13. Yang J, Zhang X, Chen X, Wang L, Yang G. Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol Ther Nucleic Acids. 2017;7:278-287. doi:10.1016/j.omtn.2017.04.010 PMid:28624203 PMCid:PMC5415550

14. Hong SB, Yang H, Manaenko A, Lu J, Mei Q, Hu Q. Potential of exosomes for the treatment of stroke. Cell Transplant. 2019;28(6):662-670. doi:10.1177/0963689718816990 PMid:30520322 PMCid:PMC6686440

15. Vahidinia Z, Azami Tameh A, Barati S, Izadpanah M, Seyed Hosseini E. Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies. Cell Mol Biol Lett. 2024;29(1):30. doi:10.1186/s11658-024-00551-3 PMid:38431569 PMCid:PMC10909300

16. Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018; 75(2):193-208. doi:10.1007/s00018-017-2595-9 PMid:28733901 PMCid:PMC8492061

17. Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci. 2014; 15(3): 4142-57. doi:10.3390/ijms15034142 PMid:24608926 PMCid:PMC3975389

18. Krylova SV, Feng D. The Machinery of Exosomes: Biogenesis, Release, and Uptake. Int J Mol Sci. 2023;24(2). doi:10.3390/ijms24021337 PMid:36674857 PMCid:PMC9865891

19. Ueno Y, Hira K, Miyamoto N, Kijima C, Inaba T, Hattori N. Pleiotropic Effects of Exosomes as a Therapy for Stroke Recovery. Int J Mol Sci. 2020; 21(18). doi:10.3390/ijms21186894 PMid:32962207 PMCid:PMC7555640

20. Forró T, Bajkó Z, Bălașa A, Bălașa R. Dysfunction of the Neurovascular Unit in Ischemic Stroke: Highlights on microRNAs and Exosomes as Potential Biomarkers and Therapy. Int J Mol Sci. 2021; 22(11). doi:10.3390/ijms22115621 PMid:34070696 PMCid:PMC8198979

21. Shahjin F, Chand S, Yelamanchili SV. Extracellular vesicles as drug delivery vehicles to the central nervous system. J Neuroimmune Pharmacol. 2020; 15:443-458. doi:10.1007/s11481-019-09875-w PMid:31485884

22. He R, Jiang Y, Shi Y, Liang J, Zhao L. Curcumin-laden exosomes target ischemic brain tissue and alleviate cerebral ischemia-reperfusion injury by inhibiting ROS-mediated mitochondrial apoptosis. Mater Sci Eng C Mater Biol Appl. 2020; 117:111314. doi:10.1016/j.msec.2020.111314 PMid:32919674

23. Liu Y, Fu N, Su J, Wang X, Li X. Rapid Enkephalin Delivery Using Exosomes to Promote Neurons Recovery in Ischemic Stroke by Inhibiting Neuronal p53/Caspase 3. Biomed Res Int. 2019; 2019:4273290. doi:10.1155/2019/4273290 PMid:30949500 PMCid:PMC6425296

24. He C, Hua W, Liu J, Fan L, Wang H, Sun G. Exosomes derived from endoplasmic reticulum-stressed liver cancer cells enhance the expression of cytokines in macrophages via the STAT3 signaling pathway. Oncol Lett. 2020;20(1):589-600. doi:10.3892/ol.2020.11609 PMid:32565984 PMCid:PMC7285763

25. Cheng L, Zhang K, Wu S, Cui M, Xu T. Focus on mesenchymal stem cell derived exosomes: opportunities and challenges in cell free therapy. Stem Cells Int. 2017;2017:6305295. doi:10.1155/2017/6305295 PMid:29410682 PMCid:PMC5749272

26. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020; 367(6478):eaau6977. doi:10.1126/science.aau6977 PMid:32029601 PMCid:PMC7717626

27. Piper RC, Katzmann DJ. Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol. 2007;23(1):519-547. doi:10.1146/annurev.cellbio.23.090506.123319 PMid:17506697 PMCid:PMC2911632

28. Luzio JP, Gray SR, Bright NA. Endosome-lysosome fusion. Portland Press Ltd; 2010. doi:10.1042/BST0381413 PMid:21118098

29. Théry C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011; 3:15. doi:10.3410/B3-15 PMid:21876726 PMCid:PMC3155154

30. Sinha S, Hoshino D, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, et al. Cortactin promotes exosome secretion by controlling branched actin dynamics. J Cell Biol. 2016;214(2):197-213. doi:10.1083/jcb.201601025 PMid:27402952 PMCid:PMC4949450

31. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012; 14(7):677-685. doi:10.1038/ncb2502 PMid:22660413

32. Batista BS, Eng WS, Pilobello KT, Hendricks-Muñoz KD, Mahal LK. Identification of a conserved glycan signature for microvesicles. J Proteome Res. 2011; 10 (10):4624-4633. doi:10.1021/pr200434y PMid:21859146 PMCid:PMC3443565

33. Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, et al. Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes. Oncotarget. 2015;6(17):15375. doi:10.18632/oncotarget.3801 PMid:25944692 PMCid:PMC4558158

34. Kalra H, Drummen GP, Mathivanan S. Focus on extracellular vesicles: introducing the next small big thing. Int J Mol Sci. 2016;17(2):170. doi:10.3390/ijms17020170 PMid:26861301 PMCid:PMC4783904

35. Geng T, Song ZY, Xing JX, Wang BX, Dai SP, Xu ZS. Exosome derived from coronary serum of patients with myocardial infarction promotes angiogenesis through the miRNA-143/IGF-IR pathway. Int J Nanomedicine. 2020;15:2647-2658. doi:10.2147/IJN.S242908 PMid:32368046 PMCid:PMC7183550

36. Xin H, Liu Z, Buller B, Li Y, Golembieski W, Gan X, et al. MiR-17-92 enriched exosomes derived from multipotent mesenchymal stromal cells enhance axon-myelin remodeling and motor electrophysiological recovery after stroke. J Cereb Blood Flow Metab. 2021; 41(5):1131-1144. doi:10.1177/0271678X20950489 PMid:32811262 PMCid:PMC8054728

37. Ling X, Zhang G, Xia Y, Zhu Q, Zhang J, Li Q, et al. Exosomes from human urine derived stem cells enhanced neurogenesis via miR 26a/HDAC6 axis after ischaemic stroke. J Cell Mol Med. 2020; 24(1): 640-654. doi:10.1111/jcmm.14774 PMid:31667951 PMCid:PMC6933407

38. Xin H, Katakowski M, Wang F, Qian JY, Liu XS, Ali MM, et al. MicroRNA-17-92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats. Stroke. 2017;48(3):747-753. doi:10.1161/STROKEAHA.116.015204 PMid:28232590 PMCid:PMC5330787

39. Xin H, Wang F, Li Y, Lu QE, Cheung WL, Zhang Y, et al. Secondary release of exosomes from astrocytes contributes to the increase in neural plasticity and improvement of functional recovery after stroke in rats treated with exosomes harvested from microRNA 133b-overexpressing multipotent mesenchymal stromal cells. Cell Transplant. 2017; 26(2): 243-257. doi:10.3727/096368916X693031 PMid:27677799 PMCid:PMC5303172

40. Chen HS, Tong HS, Zhao Y, Hong CY, Bin JP, Su L. Differential expression pattern of exosome long non-coding RNAs (lncRNAs) and MicroRNAs (miRNAs) in vascular endothelial cells under heat stroke. Med Sci Monit. 2018;24:7965. doi:10.12659/MSM.909983 PMid:30399613 PMCid:PMC6234752

41. Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013;33(11):1711-1715. doi:10.1038/jcbfm.2013.152 PMid:23963371 PMCid:PMC3824189

42. Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017; 7(3):789. doi:10.7150/thno.18133 PMid:28255367 PMCid:PMC5327650

43. Bobrie A, Colombo M, Krumeich S, Raposo G, Théry C. Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation. J Extracell Vesicles. 2012; 1(1):18397. doi:10.3402/jev.v1i0.18397 PMid:24009879 PMCid:PMC3760636

44. Rider MA, Hurwitz SN, Meckes DG Jr. ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles. Sci Rep. 2016; 6(1):23978. doi:10.1038/srep23978 PMid:27068479 PMCid:PMC4828635

45. Han Y, Jia L, Zheng Y, Li W. Salivary exosomes: emerging roles in systemic disease. Int J Biol Sci. 2018;14(6):633. doi:10.7150/ijbs.25018 PMid:29904278 PMCid:PMC6001649

46. Sokolova V, Ludwig AK, Hornung S, Rotan O, Horn PA, Epple M, et al. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces. 2011;87(1):146-150. doi:10.1016/j.colsurfb.2011.05.013 PMid:21640565

47. Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL, Simpson RJ. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics. 2010;9(2):197-208. doi:10.1074/mcp.M900152-MCP200 PMid:19837982 PMCid:PMC2830834

48. Lee K, Shao H, Weissleder R, Lee H. Acoustic purification of extracellular microvesicles. ACS Nano. 2015;9(3):2321-2327. doi:10.1021/nn506538f PMid:25672598 PMCid:PMC4373978

49. Xu Y, Hu Y, Xu S, Liu F, Gao Y. Exosomal microRNAs as potential biomarkers and therapeutic agents for acute ischemic stroke: new expectations. Front Neurol. 2022;12:747380. doi:10.3389/fneur.2021.747380 PMid:35173663 PMCid:PMC8842672

50. Makris K, Haliassos A, Chondrogianni M, Tsivgoulis G. Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research. Crit Rev Clin Lab Sci. 2018;55(5):294-328. doi:10.1080/10408363.2018.1461190 PMid:29668333

51. Osier N, Motamedi V, Edwards K, Puccio A, Diaz-Arrastia R, Kenney K, et al. Exosomes in acquired neurological disorders: new insights into pathophysiology and treatment. Mol Neurobiol. 2018;55:9280-9293. doi:10.1007/s12035-018-1054-4 PMid:29663285

52. Kanhai DA, de Kleijn DP, Kappelle LJ, Uiterwaal CS, van der Graaf Y, Pasterkamp G, et al. Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study. BMJ Open. 2014;4(1):e003824. doi:10.1136/bmjopen-2013-003824 PMid:24430876 PMCid:PMC3902438

53. Datta A, Chen CP, Sze SK. Discovery of prognostic biomarker candidates of lacunar infarction by quantitative proteomics of microvesicles enriched plasma. PLoS One. 2014; 9(4):e94663. doi:10.1371/journal.pone.0094663 PMid:24752076 PMCid:PMC3994162

54. Cipollone F, Felicioni L, Sarzani R, Ucchino S, Spigonardo F, Mandolini C, et al. A unique microRNA signature associated with plaque instability in humans. Stroke. 2011;42(9):2556-2563. doi:10.1161/STROKEAHA.110.597575 PMid:21817153

55. Ji Q, Ji Y, Peng J, Zhou X, Chen X, Zhao H, et al. Increased brain-specific MiR-9 and MiR-124 in the serum exosomes of acute ischemic stroke patients. PLoS One. 2016;11(9):e0163645. doi:10.1371/journal.pone.0163645 PMid:27661079 PMCid:PMC5035015

56. Chen Y, Song Y, Huang J, Qu M, Zhang Y, Geng J, et al. Increased circulating exosomal miRNA-223 is associated with acute ischemic stroke. Front Neurol. 2017; 8:57. doi:10.3389/fneur.2017.00057 PMid:28289400 PMCid:PMC5326773

57. Zhou J, Chen L, Chen B, Huang S, Zeng C, Wu H, et al. Increased serum exosomal miR-134 expression in the acute ischemic stroke patients. BMC Neurol. 2018;18:1-9. doi:10.1186/s12883-018-1196-z PMid:30514242 PMCid:PMC6278025

58. Jia L, Hao F, Wang W, Qu Y. Circulating miR 145 is associated with plasma high sensitivity C reactive protein in acute ischemic stroke patients. Cell Biochem Funct. 2015;33(5):314-319. doi:10.1002/cbf.3116 PMid:26096228

59. Shan Y, Hu J, Lv H, Cui X, Di W. miR-221 exerts neuroprotective effects in ischemic stroke by inhibiting the proinflammatory response. J Stroke Cerebrovasc Dis. 2021;30(2):105489. doi:10.1016/j.jstrokecerebrovasdis.2020.105489 PMid:33276305

60. Dolz S, Górriz D, Tembl JI, Sánchez D, Fortea G, Parkhutik V, et al. Circulating microRNAs as novel biomarkers of stenosis progression in asymptomatic carotid stenosis. Stroke. 2017; 48(1): 10-16. doi:10.1161/STROKEAHA.116.013650 PMid:27899750

61. Otero-Ortega L, Alonso-López E, Pérez-Mato M, Laso-García F, Gómez-de Frutos MC, Diekhorst L, et al. Circulating extracellular vesicle proteins and microRNA profiles in subcortical and cortical-subcortical ischaemic stroke. Biomedicines. 2021; 9(7):786. doi:10.3390/biomedicines9070786 PMid:34356850 PMCid:PMC8301391

62. Wang W, Li DB, Li RY, Zhou X, Yu DJ, Lan XY, et al. Diagnosis of hyperacute and acute ischaemic stroke: the potential utility of exosomal MicroRNA-21-5p and MicroRNA-30a-5p. Cerebrovasc Dis. 2018; 45(5-6):204-212. doi:10.1159/000488365 PMid:29627835

63. Li DB, Liu JL, Wang W, Li RY, Yu DJ, Lan XY, et al. Plasma exosomal miR-422a and miR-125b-2-3p serve as biomarkers for ischemic stroke. Curr Neurovasc Res. 2017;14(4):330-337. doi:10.2174/1567202614666171005153434 PMid:28982331

64. Tian T, Zhang HX, He CP, Fan S, Zhu YL, Qi C, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018; 150:137-149. doi:10.1016/j.biomaterials.2017.10.012 PMid:29040874

65. Huang M, Hong Z, Xiao C, Li L, Chen L, Cheng S, et al. Effects of exosomes on neurological function recovery for ischemic stroke in pre-clinical studies: a meta-analysis. Front Cell Neurosci. 2020; 14: 593130. doi:10.3389/fncel.2020.593130 PMid:33324166 PMCid:PMC7726242

66. Pei X, Li Y, Zhu L, Zhou Z. Astrocyte-derived exosomes suppress autophagy and ameliorate neuronal damage in experimental ischemic stroke. Exp Cell Res. 2019;382(2):111474. doi:10.1016/j.yexcr.2019.06.019 PMid:31229506

67. 67. Venkat P, Cui C, Chopp M, Zacharek A, Wang F, Landschoot-Ward J, et al. MiR-126 mediates brain endothelial cell exosome treatment-induced neurorestorative effects after stroke in type 2 diabetes mellitus mice. Stroke. 2019;50(10):2865-2874. doi:10.1161/STROKEAHA.119.025371 PMid:31394992 PMCid:PMC6756941

68. Deng Y, Chen D, Gao F, Lv H, Zhang G, Sun X, et al. Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2. J Biol Eng. 2019;13:1-18. doi:10.1186/s13036-019-0193-0 PMid:31485266 PMCid:PMC6714399

69. Jiang M, Wang H, Jin M, Yang X, Ji H, Jiang Y, et al. Exosomes from MiR-30d-5p-ADSCs reverse acute ischemic stroke-induced, autophagy-mediated brain injury by promoting M2 microglial/macrophage polarization. Cell Physiol Biochem. 2018;47(2):864-878. doi:10.1159/000490078 PMid:29807362

70. Zhao Y, Gan Y, Xu G, Hua K, Liu D. Exosomes from MSCs overexpressing microRNA-223-3p attenuate cerebral ischemia through inhibiting microglial M1 polarization mediated inflammation. Life Sci. 2020;260: 118403. doi:10.1016/j.lfs.2020.118403 PMid:32926923

71. Manuel GE, Johnson T, Liu D. Therapeutic angiogenesis of exosomes for ischemic stroke. Int J Physiol Pathophysiol Pharmacol. 2017;9(6):188-191.

72. Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, et al. Proteolytic potential of the MSC exosome proteome: Implications for an exosome mediated delivery of therapeutic proteasome. Int J Proteomics. 2012; 2012:971907. doi:10.1155/2012/971907 PMid:22852084 PMCid:PMC3407643

73. Hu GW, Li Q, Niu X, Hu B, Liu J, Zhou SM, et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice. Stem Cell Res Ther. 2015;6:1-15. doi:10.1186/scrt546 PMid:26268554 PMCid:PMC4533800

74. Liang X, Zhang L, Wang S, Han Q, Zhao RC. Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. J Cell Sci. 2016; 129(11): 2182-2189. doi:10.1242/jcs.170373 PMid:27252357

75. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15(2):261-271. doi:10.1016/j.devcel.2008.07.002 PMid:18694565 PMCid:PMC2685763

76. Chen F, Du Y, Esposito E, Liu Y, Guo S, Wang X, et al. Effects of focal cerebral ischemia on exosomal versus serum miR126. Transl Stroke Res. 2015; 6:478-484.doi:10.1007/s12975-015-0429-3 PMid:26449616

77. Wang J, Chen S, Zhang W, Chen Y, Bihl JC. Exosomes from miRNA 126‐modified endothelial progenitor cells alleviate brain injury and promote functional recovery after stroke. CNS Neurosci Ther. 2020; 26(12):1255-1265. doi:10.1111/cns.13455 PMid:33009888 PMCid:PMC7702230

78. Xu B, Zhang Y, Du XF, Li J, Zi HX, Bu JW, et al. Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity. Cell Res. 2017; 27(7): 882-897. doi:10.1038/cr.2017.62 PMid:28429770 PMCid:PMC5518987

79. Sharghi-Namini S, Tan E, Ong LLS, Ge R, Asada HH. Dll4-containing exosomes induce capillary sprout retraction in a 3D microenvironment. Sci Rep. 2014; 4(1): 4031.doi:10.1038/srep04031 PMid:24504253 PMCid:PMC3916896

80. Rahman AA, Amruta N, Pinteaux E, Bix GJ. Neurogenesis after stroke: a therapeutic perspective. Transl Stroke Res. 2021;12(1):1-14. doi:10.1007/s12975-020-00841-w PMid:32862401 PMCid:PMC7803692

81. Li Z, Wang J, Zhao C, Ren K, Xia Z, Yu H, et al. Acute blockage of notch signaling by DAPT induces neuroprotection and neurogenesis in the neonatal rat brain after stroke. Transl Stroke Res. 2016;7(2):132-140. doi:10.1007/s12975-015-0441-7 PMid:26691164

82. Zhang W, Cheng J, Vagnerova K, Ivashkova Y, Young J, Cornea A, et al. Effects of androgens on early post-ischemic neurogenesis in mice. Transl Stroke Res. 2014;5:301-311. doi:10.1007/s12975-013-0298-6 PMid:24323721

83. Li WL, Cai HH, Wang B, Chen L, Zhou QG, Luo CX, et al. Chronic fluoxetine treatment improves ischemia induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke. J Neurosci Res. 2009;87(1):112-122. doi:10.1002/jnr.21829 PMid:18711744

84. Koh SH, Park HH. Neurogenesis in stroke recovery. Transl Stroke Res. 2017;8(1):3-13. doi:10.1007/s12975-016-0460-z PMid:26987852

85. Zhao C, Sun G, Ye P, Li S, Shi Y. MicroRNA let-7d regulates the TLX/microRNA-9 cascade to control neural cell fate and neurogenesis. Sci Rep. 2013; 3(1):1329. doi:10.1038/srep01329 PMid:23435502 PMCid:PMC3580325

86. Meza-Sosa KF, Pedraza-Alva G, Pérez-Martínez L. microRNAs: key triggers of neuronal cell fate. Front Cell Neurosci. 2014;8:175. doi:10.3389/fncel.2014.00175 PMid:25009466 PMCid:PMC4070303

87. Åkerblom M, Sachdeva R, Barde I, Verp S, Gentner B, Trono D, et al. MicroRNA-124 is a subventricular zone neuronal fate determinant. J Neurosci. 2012;32(26):8879-8889. doi:10.1523/JNEUROSCI.0558-12.2012 PMid:22745489 PMCid:PMC4434222

88. Cheng LC, Pastrana E, Tavazoie M, Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci. 2009; 12(4):399-408. doi:10.1038/nn.2294 PMid:19287386 PMCid:PMC2766245

89. Song Y, Li Z, He T, Qu M, Jiang L, Li W, et al. M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124. Theranostics. 2019;9(10):2910. doi:10.7150/thno.30879 PMid:31244932 PMCid:PMC6568171

90. Xin H, Li Y, Buller B, Katakowski M, Zhang Y, Wang X, et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells. 2012;30(7):1556-1564. doi:10.1002/stem.1129 PMid:22605481 PMCid:PMC3495063

91. Xin H, Li Y, Liu Z, Wang X, Shang X, Cui Y, et al. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013;31(12): 2737-2746. doi:10.1002/stem.1409 PMid:23630198 PMCid:PMC3788061

92. Wei R, Zhang L, Hu W, Shang X, He Y, Zhang W. Zeb2/Axin2-enriched BMSC-derived exosomes promote post-stroke functional recovery by enhancing neurogenesis and neural plasticity. J Mol Neurosci. 2022;72:69-81. doi:10.1007/s12031-021-01887-7 PMid:34401997

93. Zhang G, Zhu Z, Wang H, Yu Y, Chen W, Waqas A, et al. Exosomes derived from human neural stem cells stimulated by interferon gamma improve therapeutic ability in ischemic stroke model. J Adv Res. 2020;24:435-445. doi:10.1016/j.jare.2020.05.017 PMid:32551140 PMCid:PMC7289755

94. Tassew NG, Charish J, Shabanzadeh AP, Luga V, Harada H, Farhani N, et al. Exosomes mediate mobilization of autocrine Wnt10b to promote axonal regeneration in the injured CNS. Cell Rep. 2017; 20(1): 99-111. doi:10.1016/j.celrep.2017.06.009 PMid:28683327

95. Sairanen T, Karjalainen-Lindsberg ML, Paetau A, Ijäs P, Lindsberg PJ. Apoptosis dominant in the periinfarct area of human ischaemic stroke-a possible target of antiapoptotic treatments. Brain. 2006;129(1):189-199. doi:10.1093/brain/awh645 PMid:16272167

96. Radak D, Katsiki N, Resanovic I, Jovanovic A, Sudar-Milovanovic E, Zafirovic S, et al. Apoptosis and acute brain ischemia in ischemic stroke. Curr Vasc Pharmacol. 2017;15(2):115-122. doi:10.2174/1570161115666161104095522 PMid:27823556

97. Xiao Y, Geng F, Wang G, Li X, Zhu J, Zhu W. Bone marrow-derived mesenchymal stem cells-derived exosomes prevent oligodendrocyte apoptosis through exosomal miR-134 by targeting caspase-8. J Cell Biochem. 2019;120(2):2109-2118. doi:10.1002/jcb.27519 PMid:30191592

98. Shen H, Yao X, Li H, Li X, Zhang T, Sun Q, et al. Role of exosomes derived from miR-133b modified MSCs in an experimental rat model of intracerebral hemorrhage. J Mol Neurosci. 2018; 64:421-430. doi:10.1007/s12031-018-1041-2 PMid:29455449

99. Bijian K, Takano T, Papillon J, Le Berre L, Michaud JL, Kennedy CR, et al. Actin cytoskeleton regulates extracellular matrix-dependent survival signals in glomerular epithelial cells. Am J Physiol Renal Physiol. 2005;289(6):F1313-F1323. doi:10.1152/ajprenal.00106.2005 PMid:16014575

100. Xiao B, Chai Y, Lv S, Ye M, Wu M, Xie L, et al. Endothelial cell-derived exosomes protect SH-SY5Y nerve cells against ischemia/reperfusion injury. Int J Mol Med. 2017;40(4):1201-1209. doi:10.3892/ijmm.2017.3106 PMid:28849073 PMCid:PMC5593464

101. Chen KH, Chen CH, Wallace CG, Yuen CM, Kao GS, Chen YL, et al. Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke. Oncotarget. 2016;7(46):74537. doi:10.18632/oncotarget.12902 PMid:27793019 PMCid:PMC5342685

102. Zhang Y, Liu J, Su M, Wang X, Xie C. Exosomal microRNA-22-3p alleviates cerebral ischemic injury by modulating KDM6B/BMP2/BMF axis. Stem Cell Res Ther. 2021;12:1-15.doi:10.1186/s13287-020-02091-x PMid:33546766 PMCid:PMC7863295

103. Huang X, Ding J, Li Y, Liu W, Ji J, Wang H, et al. Exosomes derived from PEDF modified adipose-derived mesenchymal stem cells ameliorate cerebral ischemia-reperfusion injury by regulation of autophagy and apoptosis. Exp Cell Res. 2018; 371(1):269-277. doi:10.1016/j.yexcr.2018.08.021 PMid:30142325

104. Zhang Y, Lian L, Fu R, Liu J, Shan X, Jin Y, et al. Microglia: the hub of intercellular communication in ischemic stroke. Front Cell Neurosci. 2022;16:889442. doi:10.3389/fncel.2022.889442 PMid:35518646 PMCid:PMC9062186

105. Li G, Xiao L, Qin H, Zhuang Q, Zhang W, Liu L, et al. RETRACTED ARTICLE: Exosomes-carried microRNA-26b-5p regulates microglia M1 polarization after cerebral ischemia/reperfusion. Cell Cycle. 2020;19(9):1022-1035. doi:10.1080/15384101.2020.1743912 PMid:32208888 PMCid:PMC7217376

106. Liu X, Zhang M, Liu H, Zhu R, He H, Zhou Y, et al. Bone marrow mesenchymal stem cell-derived exosomes attenuate cerebral ischemia-reperfusion injury-induced neuroinflammation and pyroptosis by modulating microglia M1/M2 phenotypes. Exp Neurol. 2021;341:113700. doi:10.1016/j.expneurol.2021.113700 PMid:33741350

107. Zheng Y, He R, Wang P, Shi Y, Zhao L, Liang J. Exosomes from LPS-stimulated macrophages induce neuroprotection and functional improvement after ischemic stroke by modulating microglial polarization. Biomater Sci. 2019;7(5):2037-2049. doi:10.1039/C8BM01449C PMid:30843911

108. Zhao Y, Gan Y, Xu G, Yin G, Liu D. MSCs-derived exosomes attenuate acute brain injury and inhibit microglial inflammation by reversing CysLT2R-ERK1/2 mediated microglia M1 polarization. Neurochem Res. 2020;45(5):1180-1190. doi:10.1007/s11064-020-02998-0 PMid:32112178

109. Zhang Z, Zou X, Zhang R, Xie Y, Feng Z, Li F, et al. Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1/TRAF6 signaling pathway after ischemic stroke. Aging (Albany NY). 2021;13(2):3060. doi:10.18632/aging.202466 PMid:33479185 PMCid:PMC7880318

110. Yu Y, Zhou H, Xiong Y, Liu J. Exosomal miR-199a-5p derived from endothelial cells attenuates apoptosis and inflammation in neural cells by inhibiting endoplasmic reticulum stress. Brain Res. 2020;1726:146515. doi:10.1016/j.brainres.2019.146515PMid:31634452

111. Li C, Fei K, Tian F, Gao C, Song Y. Adipose-derived mesenchymal stem cells attenuate ischemic brain injuries in rats by modulating miR-21-3p/MAT2B signaling transduction. Croat Med J. 2019;60(5):439-448. doi:10.3325/cmj.2015.56.439

112. Haupt M, Zheng X, Kuang Y, Lieschke S, Janssen L, Bosche B, et al. Lithium modulates miR-1906 levels of mesenchymal stem cell-derived extracellular vesicles contributing to poststroke neuroprotection by toll-like receptor 4 regulation. Stem Cells Transl Med. 2021;10(3):357-373. doi:10.1002/sctm.20-0086 PMid:33146943 PMCid:PMC7900596

113. Mo Y, Sun YY, Liu KY. Autophagy and inflammation in ischemic stroke. Neural Regen Res. 2020;15(8):1388-1396. doi:10.4103/1673-5374.274331 PMid:31997797 PMCid:PMC7059569

114. Chen W, Wang H, Zhu Z, Feng J, Chen L. Exosome-shuttled circSHOC2 from IPASs regulates neuronal autophagy and ameliorates ischemic brain injury via the miR-7670-3p/SIRT1 axis. Mol Ther Nucleic Acids. 2020; 22:657-672. doi:10.1016/j.omtn.2020.09.027 PMid:33230464 PMCid:PMC7581834

115. Kuang Y, Zheng X, Zhang L, Ai X, Venkataramani V, Kilic E, et al. Adipose derived mesenchymal stem cells reduce autophagy in stroke mice by extracellular vesicle transfer of miR 25. J Extracell Vesicles. 2020;10(1):e12024. doi:10.1002/jev2.12024 PMid:33304476 PMCid:PMC7710129

116. Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B. 2016;6(4):287-296.doi:10.1016/j.apsb.2016.02.001 PMid:27471669 PMCid:PMC4951582